Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Update on the use of aromatase inhibitors in early-stage breast cancer.

    Kesisis G, Makris A, Miles D.

    Breast Cancer Res. 2009;11(5):211. Epub . Review.

    PMID:
    19889200
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

    Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR.

    J Clin Oncol. 2005 Jan 20;23(3):619-29. Epub 2004 Nov 15. Review.

    PMID:
    15545664
    [PubMed - indexed for MEDLINE]
    4.

    Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.

    Dunn C, Keam SJ.

    Pharmacoeconomics. 2006;24(5):495-517. Review.

    PMID:
    16706574
    [PubMed - indexed for MEDLINE]
    5.

    Update on aromatase inhibitors in breast cancer.

    Gould RE, Garcia AA.

    Curr Opin Obstet Gynecol. 2006 Feb;18(1):41-6. Review.

    PMID:
    16493259
    [PubMed - indexed for MEDLINE]
    6.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.

    PMID:
    17993229
    [PubMed - indexed for MEDLINE]
    7.

    Exemestane: a review of its use in postmenopausal women with breast cancer.

    Deeks ED, Scott LJ.

    Drugs. 2009;69(7):889-918. doi: 10.2165/00003495-200969070-00007. Review.

    PMID:
    19441873
    [PubMed - indexed for MEDLINE]
    8.

    Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.

    Berry J.

    Clin Ther. 2005 Nov;27(11):1671-84. Review.

    PMID:
    16368441
    [PubMed - indexed for MEDLINE]
    9.

    Aromatase inhibitors in postmenopausal breast cancer patients.

    Rieber AG, Theriault RL.

    J Natl Compr Canc Netw. 2005 May;3(3):309-14. Review.

    PMID:
    16002003
    [PubMed - indexed for MEDLINE]
    10.

    Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.

    Michaud LB.

    Am J Health Syst Pharm. 2005 Feb 1;62(3):266-73. Review.

    PMID:
    15719584
    [PubMed - indexed for MEDLINE]
    11.

    Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.

    Litsas G.

    Oncol Nurs Forum. 2008 Jul;35(4):714-21. Review.

    PMID:
    18591176
    [PubMed - indexed for MEDLINE]
    12.

    Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer.

    Sanford M, Plosker GL.

    Drugs. 2008;68(9):1319-40. Review.

    PMID:
    18547136
    [PubMed - indexed for MEDLINE]
    13.

    Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.

    Gibson LJ, Dawson CK, Lawrence DH, Bliss JM.

    Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003370. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD003370.

    PMID:
    17253488
    [PubMed - indexed for MEDLINE]
    14.

    Aromatase inhibitors: a new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women.

    Colozza M, Califano R, Minenza E, Dinh P, Azambuja E.

    Mini Rev Med Chem. 2008 Jun;8(6):564-74. Review.

    PMID:
    18537711
    [PubMed - indexed for MEDLINE]
    15.

    Aromatase inhibitors in the treatment of early and advanced breast cancer.

    Joensuu H, Ejlertsen B, Lønning PE, Rutqvist LE.

    Acta Oncol. 2005;44(1):23-31. Review.

    PMID:
    15848903
    [PubMed - indexed for MEDLINE]
    16.

    Adjuvant aromatase inhibitors following tamoxifen for early-stage breast cancer in postmenopausal women: what do we really know?

    Chung CT, Carlson RW.

    Clin Breast Cancer. 2004 Sep;5 Suppl 1:S18-23. Review.

    PMID:
    15347435
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors.

    Brufsky AM.

    Clin Breast Cancer. 2007 Dec;8 Suppl 1:S22-34. Review.

    PMID:
    18282367
    [PubMed - indexed for MEDLINE]
    18.

    Aromatase inhibitors: a new paradigm in breast cancer treatment.

    Narashimamurthy J, Rao AR, Sastry GN.

    Curr Med Chem Anticancer Agents. 2004 Nov;4(6):523-34. Review.

    PMID:
    15579017
    [PubMed - indexed for MEDLINE]
    19.

    Optimal sequence of hormonotherapy in advanced breast cancer.

    Bertelli G, Paridaens R.

    Curr Opin Oncol. 2006 Nov;18(6):572-7. Review.

    PMID:
    16988577
    [PubMed - indexed for MEDLINE]
    20.

    Adjuvant endocrine treatment of early breast cancer.

    Lønning PE.

    Hematol Oncol Clin North Am. 2007 Apr;21(2):223-38. Review.

    PMID:
    17512446
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk